Drug interactions between MetroLotion and warfarin
| Results for the following 2 drugs: |
|---|
| MetroLotion (metronidazole topical) |
| warfarin |
Interactions between your selected drugs
warfarin ↔ metronidazole
Applies to:warfarin and MetroLotion (metronidazole topical)
MONITOR: Coadministration with vaginal metronidazole may enhance the hypoprothrombinemic effect of warfarin and other oral anticoagulants. The proposed mechanism is metronidazole inhibition of CYP450 2C9, the isoenzyme responsible for the metabolic clearance of the more active S(-) enantiomer of warfarin. The interaction has been reported with systemically administered metronidazole and warfarin. Significant bleeding and elevation of prothrombin time have been observed. No data are available for vaginally administered metronidazole. Although peak serum levels and systemic exposure are substantially lower than in systemic administration, the possibility of an interaction cannot be excluded.
MANAGEMENT: The potential for interaction with warfarin and other oral anticoagulants should be considered during coadministration with vaginal preparations of metronidazole. The INR should be checked frequently and anticoagulant dosage adjusted accordingly, particularly following initiation and discontinuation of metronidazole therapy in patients who are stabilized on their anticoagulant regimen. Patients should be advised to promptly report any signs of bleeding to their physician, including pain, swelling, headache, dizziness, weakness, prolonged bleeding from cuts, increased menstrual flow, vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or brown urine, or red or black stools.
See also...
Drug Interaction Classification
The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2012 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
